1
Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)
Condition(s):Complicated Intra-Abdominal InfectionsLast Updated:February 17, 2017Completed
Evaluable: 3759 Clinical Trials, Page 1 of 376
Hide Studies Not Open or Pending
2
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Condition(s):Non-Erosive Gastro-Esophageal Reflux Disease; HeartburnLast Updated:January 4, 2023Completed
3
Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation
Condition(s):Stem Cell Transplantation, HematopoieticLast Updated:October 16, 2015Completed
4
Effects of Continuous Anterior Chest Compression
Condition(s):EvaluableLast Updated:May 25, 2023Recruiting
5
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
Condition(s):Complicated Intra-abdominal InfectionsLast Updated:January 17, 2023Completed
6
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
Condition(s):PneumoniaLast Updated:February 26, 2010Completed
7
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
Condition(s):PneumoniaLast Updated:February 26, 2010Completed
8
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
Condition(s):Appendicitis; Cholecystitis; Diverticulitis; Intra-Abdominal Abscess; Intra-Abdominal Infection; PeritonitisLast Updated:February 25, 2013Completed
9
Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Condition(s):ContraceptionLast Updated:August 6, 2019Completed
10
Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Condition(s):Early Breast CancerLast Updated:November 9, 2021Terminated